Page 11 - HOI Outcomes 2019
P. 11

 HRM: OPIOID USE AND READMISSIONS
Opioid overdoses continue to increase in the U.S. In 2018 at HOI, readmissions related to patients on opioids decreased.
Readmission Rate for Patients on Opioids
HRM: ANTICOAGULANT USE AND READMISSIONS
Anticoagulants are prescribed based on surgical risk factors. HOI’s robust venous thromboembolism (VTE - blood clot) prevention protocol has decreased readmissions for coagulation concerns.
Readmission Rate for Patients on Anticoagulants
(Lower is better)
(Lower is better)
    9.1%
7.7%
6.8%
21.6%
21.5%
21.4%
21.5%
   3.1%
   HOI
HOI
2017
State
2018
2017 State
2018
    Source: Health Services Advisory Group HOI High-Risk Medication Facility Report received May 2019
Source: Health Services Advisory Group HOI High-Risk Medication Facility Report received May 2019
HRM: DIABETIC AGENTS USE AND READMISSIONS
Abnormally increased blood glucose levels during peri-operative care can increase a patient’s risk of surgical complications that may result in readmission. HOI’s readmission rate for patients on diabetic agents is well below the average, as shown here.
HOI Readmission Rate for Patients on Diabetic Agents
(Lower is better)
25% 20% 15% 10% 5% 0%
Q1 2017
Source: Health Services Advisory Group HOI High-Risk Medication Facility Report received May 2019
Q2 2018
Q3 2018
Q4 2018
        Q2 2017
Q3 2017
Q4 2017
Q1 2018
 HOI State
  2019 OUTCOMES REPORT | 11


























































   9   10   11   12   13